AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 21146229
Drug: 0.3 mg
RxNorm normalized name: biotin 0.3 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.3 mg quarterly
Trial: 21146229
Drug: 0.5 mg
RxNorm normalized name: biotin 0.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 mg quarterly
Trial: 21146229
Drug: 0.3 mg
RxNorm normalized name: biotin 0.3 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.3 mg monthly
Trial: 21146229
Drug: 0.3 mg
RxNorm normalized name: biotin 0.3 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.3 mg quarterly and 0.5 mg quarterly
Trial: 14622685
Drug: Transdermal fentanyl
RxNorm normalized name: fentanyl Transdermal System
DrugBank: Fentanyl (DB00813)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Transdermal fentanyl with local heat applied for 4 hours and again for 1 hour at 24 hours (Session B)
Trial: 14622685
Drug: Transdermal fentanyl
RxNorm normalized name: fentanyl Transdermal System
DrugBank: Fentanyl (DB00813)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Transdermal fentanyl without local heat (Session A)
Trial: 14622685
Drug: Transdermal fentanyl
RxNorm normalized name: fentanyl Transdermal System
DrugBank: Fentanyl (DB00813)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Transdermal fentanyl with heat applied for 15 minutes at 12 and 16 hours (Session C)
Trial: 14622685
Drug: Transdermal fentanyl
RxNorm normalized name: fentanyl Transdermal System
DrugBank: Fentanyl (DB00813)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Transdermal fentanyl without heat (Session A)
Trial: 10890611
Drug: Control (ventilator
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (ventilator therapy without inhaled nitric oxide)
Trial: 6419710
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose heparin
Trial: 1702235
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose heparin and graded compression stockings
Trial: 21573819
Drug: Daily sulphate‐bicarbonate‐calcium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily sulphate‐bicarbonate‐calcium mineral water bath
Trial: 17307426
Drug: rosiglitazone 4
RxNorm normalized name: rosiglitazone 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rosiglitazone 4 mg once daily
Trial: 17307426
Drug: metformin 850
RxNorm normalized name: metFORMIN 850 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: metformin 850 mg twice daily
Trial: 14985866
Drug: 99mTc-DTPA excretion
RxNorm normalized name: DTPA
DrugBank: Pentetic acid (DB14007)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 99mTc-DTPA excretion method
Trial: 11794148
Drug: Fondaparinux 2.5
RxNorm normalized name: FONDAPARINUX 2.5MG/0.5ML INJ SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fondaparinux 2.5 mg once daily, initiated postoperatively
Trial: 11794148
Drug: Enoxaparin 40
RxNorm normalized name: ENOXAPARIN 40MG/0.4ML INJ
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enoxaparin 40 mg once daily, initiated preoperatively
Trial: 9608824
Drug: Nasal administration
RxNorm normalized name: Novel Influenza-H1N1-09, live virus for nasal administration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nasal administration of fenoterol
Trial: 9608824
Drug: Inhalation of
RxNorm normalized name: Ocean brand of sodium chloride Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhalation of beta2-agonists
Trial: 9608824
Drug: Frequent administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Frequent administration of small doses of beta2-agonists
Trial: 9356783
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no drug treatment during washout)
Trial: 11545
Drug: Corticosteroids and
RxNorm normalized name: Corticosteroids and mydriatics in combination
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Corticosteroids and Salazopyrin treatment postoperatively for 33 weeks
Trial: 11545
Drug: No medical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No medical treatment postoperatively
Trial: 28453348
Drug: Moist hot
RxNorm normalized name: Red Hot
DrugBank: Capsaicin (DB06774)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Moist hot pack treatment
Trial: 21619383
Drug: AZD1305 (test
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AZD1305 (test dose 250 mg, evening dose 125 mg on day 1, maintenance dose 125 mg twice daily)
Trial: 21619383
Drug: AZD1305 (test
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AZD1305 (test dose 500 mg, placebo evening dose, maintenance dose 125 mg twice daily)
Trial: 21619383
Drug: Placebo (placebo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (placebo test and maintenance dose)
Trial: 11069791
Drug: Supervised IPT
RxNorm normalized name: Iptacopan
DrugBank: Iptacopan (DB16200)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Supervised IPT (900 mg twice weekly for 6 months, Regimen A)
Trial: 11069791
Drug: Unsupervised IPT
RxNorm normalized name: Iptacopan
DrugBank: Iptacopan (DB16200)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Unsupervised IPT (900 mg twice weekly for 6 months, Regimen B)
Trial: 11069791
Drug: Unsupervised IPT
RxNorm normalized name: Iptacopan
DrugBank: Iptacopan (DB16200)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Unsupervised IPT (300 mg daily for 6 months, Regimen C)
Trial: 9713652
Drug: Daily rhuIL-2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily rhuIL-2 therapy
Trial: 9713652
Drug: Pulse rhuIL-2
RxNorm normalized name: DULSE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pulse rhuIL-2 therapy
Trial: 7767241
Drug: Monthly feedback
RxNorm normalized name: tobramycin
DrugBank: Tobramycin (DB00684)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Monthly feedback with peer comparison
Trial: 27155741
Drug: Placebo plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo plus fulvestrant 500 mg
Trial: 30157389
Drug: Emicizumab 1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Emicizumab 1.5 mg/kg/week (group A)
Trial: 30157389
Drug: Emicizumab 3.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Emicizumab 3.0 mg/kg every 2 weeks (group B)
Trial: 19102241
Drug: Anesthetic modes
RxNorm normalized name: Gelato Anesthetic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anesthetic modes and reflex exposures in the complex therapy
Trial: 19102241
Drug: Conventional complex
RxNorm normalized name: hesperidin complex
DrugBank: Citrus bioflavonoids (DB14586)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional complex therapy (control group)
Trial: 16078205
Drug: Levetiracetam (add-on
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levetiracetam (add-on therapy, starting dose of 500 mg twice per day up to 50 mg/kg/day)
Trial: 7566945
Drug: Acenocoumarol treatment
RxNorm normalized name: acenocoumarol
DrugBank: Acenocoumarol (DB01418)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acenocoumarol treatment for at least 2 years (duration of treatment: 75.0 ± 52 months)
Trial: 7566945
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (not treated by anticoagulant)
Trial: 2255215
Drug: Transdermal nicotine
RxNorm normalized name: nicotine Transdermal System
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Transdermal nicotine patch (Nicolan)
Trial: 348615
Drug: Mitomycin C,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mitomycin C, 0.8 mg/kg body weight intravenously, twice a week for 5 weeks after surgery
Trial: 31014975
Drug: Patients identifying
RxNorm normalized name: patent blue violet
DrugBank: Patent Blue (DB13967)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patients identifying medications by name (brand name: 50%; generic: 21%)
Trial: 28624340
Drug: Combination to
RxNorm normalized name: OCTINOXATE 30 mg in 1 mL / TITANIUM DIOXIDE 47 mg in 1 mL TOPICAL CREAM [Garnier Skin Renew Miracle Skin Perfector Combination to Oily Skin BB Broad Spectrum SPF 20 Sunscreen]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination to Denosumab
Trial: 21634303
Drug: Quercetin supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quercetin supplementation (1 g/day for 6 weeks)
Trial: 18217149
Drug: 150 mg/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 150 mg/day clopidogrel
Trial: 18217149
Drug: 75 mg/day
RxNorm normalized name: Lyllana 0.075 MG/Day Transdermal Patch
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 75 mg/day clopidogrel
Trial: 11742194
Drug: Esomeprazole 20
RxNorm normalized name: esomeprazole 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Esomeprazole 20 mg + amoxicillin 1 g + clarithromycin 500 mg (EAC)
Trial: 11742194
Drug: Omeprazole 20
RxNorm normalized name: omeprazole 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole 20 mg + amoxicillin 1 g + clarithromycin 500 mg (OAC)
Trial: 9580087
Drug: Ceftazidime (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ceftazidime (2 g/8 h) plus Amikacin (15 mg/kg/day)
Trial: 3315775
Drug: Oral ribavirin
RxNorm normalized name: Ribavirin
DrugBank: Ribavirin (DB00811)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Oral ribavirin (800-1600 mg/day for 7 days)
Trial: 6725033
Drug: Osteopathic manipulative
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Osteopathic manipulative treatment
Trial: 26059103
Drug: Prophylactic administration
RxNorm normalized name: polylactic acid-polyglycolic acid copolymer
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prophylactic administration of 70 mg/kg bovine surfactant within 30 minutes after birth
Trial: 26059103
Drug: Early treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Early treatment with surfactant therapy for established RDS
Trial: 24032191
Drug: Abdominal acupuncture
RxNorm normalized name: PAD,ABDOMINAL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Abdominal acupuncture therapy
Trial: 20447648
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of both (Diet + Activity)
Trial: 9321530
Drug: cA2 (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: cA2 (10 mg/kg)
Trial: 9321530
Drug: cA2 (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: cA2 (20 mg/kg)
Trial: 2070884
Drug: 360 degrees
RxNorm normalized name: NEEDLE 20G 1IN BENT 90 DEGREES
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 360 degrees of peripheral circumferential treatment
Trial: 2070884
Drug: Feeder vessel
RxNorm normalized name: acellular tissue engineered vessel Drug Implant [Symvess]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Feeder vessel treatment
Trial: 6418191
Drug: No analgesic
RxNorm normalized name: Analgesic Balm GRX
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No analgesic supplementation
Trial: 6418191
Drug: Fentanyl and
RxNorm normalized name: Fentanyl
DrugBank: Fentanyl (DB00813)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Fentanyl and Alfentanil (all doses)
Trial: 6418191
Drug: Alfentanil (larger
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alfentanil (larger doses)
Trial: 23296186
Drug: dextroamphetamine (dAMPH)
DrugBank: Dextroamphetamine (DB01576)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: dextroamphetamine (dAMPH) infusion (0.3mg/kg)
Trial: 23296186
Drug: baseline dopamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: baseline dopamine D2/3 receptor availability with [(123)I]IBZM SPECT
Trial: 21788428
Drug: 0.75 μg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.75 μg LPS/kg BW (L75)
Trial: 21788428
Drug: 1.50 μg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.50 μg LPS/kg BW (L150)
Trial: 21788428
Drug: Control (0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (0 μg LPS/kg BW)
Trial: 21788428
Drug: LPS (0.75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LPS (0.75 μg and 1.50 μg)
Trial: 15287454
Drug: Intracranial pressure
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intracranial pressure (ICP) targeted therapy
Trial: 16696859
Drug: Pegylated interferon
RxNorm normalized name: Pegylated interferon alfa-2a
DrugBank: Peginterferon alfa-2a (DB00008)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pegylated interferon alpha-2b and ribavirin (48 weeks treatment)
Trial: 15548142
Drug: Low-dose acetylsalicylic
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose acetylsalicylic acid (ASA) 0.5 mg/kg/day
Trial: 3300276
Drug: Chemotherapy (CT)
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy (CT) plus liver directed radiotherapy (RT)
Trial: 3300276
Drug: Less than
RxNorm normalized name: IgA less than or equal to 50 mcg/mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Less than full RT doses
Trial: 23179507
Drug: Cognitive-behavioural play
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive-behavioural play therapy (not performed)
Trial: 23179507
Drug: Sham play
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sham play therapy
Trial: 18212498
Drug: Intravenous iron
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous iron sucrose (Venofer(R), 100 mg iron, twice a week for 8 weeks, then once a week for another 4 weeks)
Trial: 18212498
Drug: Oral ferrous
RxNorm normalized name: ferrous fumarate Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral ferrous succinate (200 mg t.i.d. for 12 weeks)
Trial: 10735703
Drug: Heparin-bonded CPB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparin-bonded CPB
Trial: 10735703
Drug: Non-heparin-bonded CPB
RxNorm normalized name: SKIN BOND NON-FLAMMABLE CEMENT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-heparin-bonded CPB
Trial: 1286498
Drug: Flumazenil (mean
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flumazenil (mean dose, 0.76 mg)
Trial: 1286498
Drug: Placebo (mean
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (mean dose, 8.9 ml)
Trial: 31627715
Drug: Massive Haemorrhage
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Massive Haemorrhage protocol including systematic early administration of tranexamic acid (TXA)
Trial: 27151015
Drug: CIK cell
RxNorm normalized name: Testone CIK KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CIK cell infusion
Trial: 25409678
Drug: Citrate 4%
RxNorm normalized name: SODIUM CITRATE 4% SOLN
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Citrate 4% catheter lock solution
Trial: 25409678
Drug: Unfractionated heparin
RxNorm normalized name: Unfractionated heparin
DrugBank: Heparin (DB01109)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Unfractionated heparin at a concentration of 5,000 IU/mL
Trial: 21066885
Drug: Combined treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined treatment group (CTG) with Shenmai Injection (SMI) and enteral nutrition
Trial: 29147070
Drug: Combined treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined treatment group (CTG)
Trial: 8626963
Drug: Nocturnal oxygen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nocturnal oxygen therapy
Trial: 21769617
Drug: 10 ml
RxNorm normalized name: Vial Empty 10 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 ml of saline
Trial: 300825
Drug: Systemic antibiotics
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Systemic antibiotics before and after the operation
Trial: 300825
Drug: No prophylactic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No prophylactic systemic antibiotics
Trial: 31286172
Drug: Arm and
RxNorm normalized name: Arm and Hammer Simply Saline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Arm and leg cycling (A&L)
Trial: 28108978
Drug: Short-course intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Short-course intravenous levofloxacin (750 mg/day for 5 days)
Trial: 28108978
Drug: Conventional intravenous/oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional intravenous/oral levofloxacin (500 mg/day for 7-14 days)
Trial: 28108978
Drug: Short-course intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Short-course intravenous levofloxacin (750 mg/day)
Trial: 28108978
Drug: Conventional intravenous/oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional intravenous/oral levofloxacin (500 mg/day)
Trial: 25040296
Drug: Pulsed dye
RxNorm normalized name: amaranth dye
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pulsed dye laser (PDL) treatment (wavelength 595 nm; fluence 8 J cm(‐2); pulse duration 0.5 ms; spot size 10 mm)
Trial: 24035402
Drug: Computer-assisted cognitive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Computer-assisted cognitive remediation therapy (CACR)
Trial: 20427547
Drug: Multidimensional Family
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multidimensional Family Therapy-Detention to Community (MDFT-DTC)
Trial: 19928509
Drug: Intravenous lidocaine
RxNorm normalized name: Lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous lidocaine (IVL) 3 mg x kg(‐1) for 30 min
Trial: 19928509
Drug: Saline 100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saline 100 ml for 30 min
Trial: 17703241
Drug: Budesonide-formoterol as
RxNorm normalized name: budesonide / formoterol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Budesonide-formoterol as maintenance and reliever treatment
Trial: 17703241
Drug: Salmeterol-fluticasone as
RxNorm normalized name: FLUTICASONE/SALMETEROL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Salmeterol-fluticasone as maintenance medication plus salbutamol as needed
Trial: 14718489
Drug: Intramuscular testosterone
RxNorm normalized name: Testosterone
DrugBank: (1,2,6,7-3H)Testosterone (DB14093)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intramuscular testosterone (200 mg every 3 weeks)
Trial: 12761015
Drug: 2-mL volume
RxNorm normalized name: VOLUME EXPANDERS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2-mL volume of epidural fentanyl
Trial: 12761015
Drug: 10-mL volume
RxNorm normalized name: hydrogen peroxide
DrugBank: Hydrogen peroxide (DB11091)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 10-mL volume of epidural fentanyl
Trial: 12761015
Drug: 20-mL volume
RxNorm normalized name: VOLUME EXPANDERS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20-mL volume of epidural fentanyl
Trial: 12761015
Drug: All groups
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All groups (2-mL, 10-mL, 20-mL)
Trial: 7782978
Drug: Intensive oral
RxNorm normalized name: Uricalm Intensive Oral Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intensive oral hygiene training program with detailed information, self-diagnosis training, and ongoing motivation.
Trial: 7782978
Drug: Shorter oral
RxNorm normalized name: SALICYLIC ACID 2 mg in 100 mL TOPICAL SHAMPOO [FYENACEL CALMING SHOOTER CELLANDIR HAIR LOSS-Shampoo]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Shorter oral hygiene training program without motivation and feedback.
Trial: 7782978
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group with no motivation sessions or oral hygiene training.
Trial: 488428
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg progesterone injection
Trial: 31182338
Drug: Glimepiride 2
RxNorm normalized name: glimepiride 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glimepiride 2 mg/day
Trial: 24845394
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg of transdermal testosterone cream (TTC)
Trial: 24845394
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg of transdermal testosterone cream (TTC)
Trial: 17441983
Drug: Astra Tech
RxNorm normalized name: carbamide peroxide
DrugBank: Carbamide peroxide (DB11129)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Astra Tech Single Tooth Implant (ST) with Microthread
Trial: 17441983
Drug: Astra Tech
RxNorm normalized name: carbamide peroxide
DrugBank: Carbamide peroxide (DB11129)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Astra Tech TiOblast Implant (TB) without Microthread
Trial: 15197140
Drug: Repaglinide (1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Repaglinide (1.5 to 12 mg/d)
Trial: 15197140
Drug: Glyburide (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glyburide (5 to 20 mg/d)
Trial: 11443622
Drug: Induction chemoradiotherapy
RxNorm normalized name: human sputum, Bordetella pertussis infected
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Induction chemoradiotherapy with cisplatin (60 mg/m(2) on Days 1 and 22) and etoposide (100 mg/m(2) on Days 1, 2, 3, 22, 23, 24) plus 5940 cGy radiation in 180-cGy fractions over 6 weeks
Trial: 351355
Drug: Ethanol (0.75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ethanol (0.75 g/kg)
Trial: 31342445
Drug: Treatment-as-usual (TAU)
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment-as-usual (TAU) (n=24)
Trial: 28835597
Drug: 10% casein
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10% casein phosphopeptide‐amorphous calcium phosphate (CPP‐ACP) paste applied twice a day for 36 months
Trial: 28835597
Drug: Fluoridated toothpaste
RxNorm normalized name: sodium fluoride Toothpaste
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluoridated toothpaste applied twice a day for 36 months
Trial: 18393298
Drug: Single dose
RxNorm normalized name: Citrucel Single Dose Packets (Orange)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single dose of lofexidine hydrochloride (1.2 mg and 2.0 mg)
Trial: 18393298
Drug: Multidose of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multidose of lofexidine hydrochloride (0.4 mg)